findmyKOL
Clinical trialNCT06484920RecruitingPhase 2Interventional

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

SponsorRita AssiEnrollment24B-cell LymphomaRefractory Hodgkin LymphomaRefractory Non-Hodgkin LymphomaRelapsed Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase II single-center open label trial of the combination of ATRA and pembrolizumab treatment in patients with histologically proven, relapsed or refractory Hodgkin Lymphoma or B-Non-Hodgkin-lymphoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana, United States

    Rita Assi, MD
    Recruiting
  • Sidney and Lois Eskenazi Hospital

    Indianapolis, Indiana, United States

    Ahmad Al-Hader
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Tretinoin →Pembrolizumab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Nov 2024
Primary completion
31 Dec 2027
Completion
30 Sept 2029
Last update posted
10 Feb 2026
Registered enrollment
24
Registry id
NCT06484920
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.